| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |